Toward understanding ambulatory activity decline in parkinson disease

Physical Therapy

Volumn 95, Issue 8, 2015, Pages 1142-1150

  Cavanaugh, James T ^a   Ellis, Terry D ^b   Earhart, Gammon M ^c   Ford, Matthew P ^d   Bo Foreman, K ^e   Dibble, Leland E ^e  

^a UNIVERSITY OF NEW ENGLAND   (United States)

^b BOSTON UNIVERSITY   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d SAMFORD UNIVERSITY   (United States)

^e UNIVERSITY OF UTAH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIPARKINSON AGENT; LEVODOPA;

AGED; BODY EQUILIBRIUM; CLINICAL TRIAL; DISABILITY; DISEASE COURSE; FEMALE; HUMAN; LONGITUDINAL STUDY; MALE; MULTICENTER STUDY; NEUROLOGIC GAIT DISORDER; PARKINSON DISEASE; PATHOPHYSIOLOGY; PROSPECTIVE STUDY; QUALITY OF LIFE; QUESTIONNAIRE; SELF CONCEPT; UPPER LIMB; WALKING DIFFICULTY;

AGED; ANTIPARKINSON AGENTS; DISABILITY EVALUATION; DISEASE PROGRESSION; FEMALE; GAIT DISORDERS, NEUROLOGIC; HUMANS; LEVODOPA; LONGITUDINAL STUDIES; MALE; MOBILITY LIMITATION; PARKINSON DISEASE; POSTURAL BALANCE; PROSPECTIVE STUDIES; QUALITY OF LIFE; SELF EFFICACY; SURVEYS AND QUESTIONNAIRES; UPPER EXTREMITY;

EID: 84938632050     PISSN: 00319023     EISSN: 15386724     Source Type: Journal    
DOI: 10.2522/ptj.20140498     Document Type: Article

References (46)

1. Jette AM. Toward a common language for function, disability, and health. Phys Ther. 2006;86:726–734
2. International Classification of Functioning, Disability and Health: ICF. Geneva, Switzerland: World Health Organization; 2001
3. Shulman LM, Gruber-Baldini AL, Anderson KE, et al. The evolution of disability in Parkinson disease. Mov Disord. 2008;23:790-796
4. Alves G, Wentzel-Larsen T, Aarsland D, Larsen JP. Progression of motor impairment and disability in Parkinson disease: a population-based study. Neurology. 2005; 65:1436–1441
5. Jankovic J, Kapadia AS. Functional decline in Parkinson disease. Arch Neurol. 2001; 58:1611–1615
6. Poewe W, Mahlknecht P. The clinical progression of Parkinson’s disease. Parkinsonism Relat Disord. 2009;15(suppl 4):S28–S32
7. Shulman LM. Understanding disability in Parkinson’s disease. Mov Disord. 2010; 25(suppl 1):S131–S135
8. Cavanaugh JT, Ellis TE, Earhart GM, et al. Capturing ambulatory activity in Parkinson’s disease. J Neurol Phys Ther. 2012; 36:51–57
9. White DK, Wagenaar RC, Del Olmo M, Ellis T. Test-retest reliability of 24 hours of activity monitoring in individuals with Parkinson’s disease in home and community. Neurorehabil Neural Repair. 2006;21: 327–340
10. White DK, Wagenaar RC, Ellis T. Monitoring activity in individuals with Parkinson disease: a validity study. J Neurol Phys Ther. 2006;30:12–21
11. Skidmore FM, Mackman CA, Pav B, et al. Daily ambulatory activity levels in idiopathic Parkinson disease. J Rehabil Res Dev. 2008;45:1343–1348
12. Tudor-Locke C, Hatano Y, Pangrazi RP, Kang M. Revisiting “how many steps are enough?” Med Sci Sports Exerc. 2008;40(7 suppl):S537–S543
13. Tudor-Locke C, Craig CL, Aoyagi Y, et al. How many steps/day are enough? For older adults and special populations. Int J Behav Nutr Phys Act. 2011;8:80
14. Tudor-Locke C, Washington TL, Hart TL. Expected values for steps/day in special populations. Prev Med. 2009;49:3–11
15. Earhart GM, Falvo MJ. Parkinson disease and exercise. Compr Physiol. 2013;3:833-848
16. Office of Disease Prevention and Health Promotion. Physical activity guidelines. Available at: http://www.health.gov/paguidelines/. Accessed April 10, 2015
17. Cavanaugh JT, Gappmaier VO, Dibble LE, Gappmaier E. Ambulatory activity in individuals with multiple sclerosis. J Neurol Phys Ther. 2011;35:26–33
18. Bowden MG, Hannold EM, Nair PM, et al. Beyond gait speed: a case report of a multidimensional approach to locomotor rehabilitation outcomes in incomplete spinal cord injury. J Neurol Phys Ther. 2008; 32:129–138
19. Dibble LE, Cavanaugh JT, Earhart GM, et al. Charting the progression of disability in Parkinson disease: study protocol for a prospective longitudinal cohort study. BMC Neurol. 2010;10:110
20. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry. 1992;55:181–184
21. Goetz CG, Poewe W, Dubois B, et al. The MDS-UPDRS: How to Apply the New UPDRS in Practice and Research Settings. Milwaukee, WI: International Parkinson and Movement Disorder Society; 2006
22. Goetz CG, Tilley BC, Shaftman SR, et al. Movement Disorder Society–sponsored revision of the Unified Parkinson’s Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord. 2008;23:2129–2170
23. Steffen T, Seney M. Test-retest reliability and minimal detectable change on balance and ambulation tests, the 36-item Short- Form Health Survey, and the Unified Parkinson Disease Rating Scale in people with parkinsonism. Phys Ther. 2008;88:733-746
24. Yesavage JA, Brink TL, Rose TL, et al. Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res. 1982;17:37–49
25. Mondolo F, Jahanshahi M, Grana A, et al. The validity of the Hospital Anxiety and Depression Scale and the Geriatric Depression Scale in Parkinson’s disease. Behav Neurol. 2006;17:109–115
26. Berg KO, Wood-Dauphineé SL, Williams JI, Maki B. Measuring balance in the elderly: validation of an instrument. Can J Public Health. 1992;83(suppl 2):S7–S11
27. Qutubuddin AA, Pegg PO, Cifu DX, et al. Validating the Berg Balance Scale for patients with Parkinson’s disease: a key to rehabilitation evaluation. Arch Phys Med Rehabil. 2005;86:789–792
28. Walker ML, Austin AG, Banke GM, et al. Reference group data for the Functional Gait Assessment. Phys Ther. 2007;87: 1468–1477
29. Wrisley DM, Marchetti GF, Kuharsky DK, Whitney SL. Reliability, internal consistency, and validity of data obtained with the Functional Gait Assessment. Phys Ther. 2004;4:906–918
30. Brusse KJ, Zimdars S, Zalewski KR, Steffen TM. Testing functional performance in people with Parkinson disease. Phys Ther. 2005;85:134–141
31. ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the sixminute walk test. Am J Respir Crit Care Med. 2002;166:111–117
32. Earhart GM, Cavanaugh JT, Ellis T, et al. The 9-hole PEG test of upper extremity function: average values, test-retest reliability, and performance in people with Parkinson disease. J Neurol Phys Ther. 2011;35:157–163
33. Munneke M, de Jong Z, Zwinderman AH, et al. The value of a continuous ambulatory activity monitor to quantify the amount and intensity of daily activity in patients with rheumatoid arthritis. J Rheumatol. 2001;28:745–750
34. Manns PJ, Baldwin E. Ambulatory activity of stroke survivors: measurement options for dose, intensity, and variability of activity. Stroke. 2009;40:864–867
35. Den Oudsten BL, Van Heck GL, De Vries J. The suitability of patient-based measures in the field of Parkinson’s disease: a systematic review. Mov Disord. 2007;22: 1390–1401
36. Jenkinson C, Fitzpatrick R, Peto V, et al. The Parkinson’s Disease Questionnaire (PDQ-39): development and validation of a Parkinson’s disease summary index score. Age Ageing. 1997;26:353–357
37. Resnick B, Jenkins LS. Testing the reliability and validity of the Self-Efficacy for Exercise Scale. Nurs Res. 2000;49:154–159
38. Tomlinson CL, Stowe R, Patel S, et al. Systematic review of levodopa dose equivalency reporting in Parkinson’s disease. Mov Disord. 2010;25:2649–2653
39. Lakens D. Calculating and reporting effect sizes to facilitate cumulative science: a practical primer for t-tests and ANOVAs. Front Psychol. 2013;4:863
40. McCambridge J, Witton J, Elbourne DR. Systematic review of the Hawthorne effect: new concepts are needed to study research participation effects. J Clin Epidemiol. 2014;67:267–277
41. Ouellette JA, Wood W. Habit and intention in everyday life: the multiple processes by which past behavior predicts future behavior. Psychol Bull. 1998;124:54–74
42. Ellis T, Cavanaugh JT, Earhart GM, et al. Factors associated with exercise behavior in people with Parkinson disease. Phys Ther. 2011;91:1838–1848
43. Manns PJ, Dunstan DW, Owen N, Healy GN. Addressing the nonexercise part of the activity continuum: a more realistic and achievable approach to activity programming for adults with mobility disability? Phys Ther. 2012;92:614–625
44. Ellis T, Motl RW. Physical activity behavior change in persons with neurologic disorders: overview and examples from Parkinson disease and multiple sclerosis. J Neurol Phys Ther. 2013;37:85–90
45. Paterson DH, Warburton DE. Physical activity and functional limitations in older adults: a systematic review related to Canada’s Physical Activity Guidelines. Int J Behav Nutr Phys Act. 2010;7:38
46. Spirduso WW, Cronin DL. Exercise doseresponse effects on quality of life and independent living in older adults. Med Sci Sports Exerc. 2001;33(6 suppl):S598-S608.